← Browse by Condition
Medical Condition
non small cell lung cancer nsclc
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
NCT07087223 Phase 1, Phase 2
Recruiting
Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure
Enrollment
42 pts
Location
China
Sponsor
Peking University Cancer Hospi...
NCT07349537 Phase 1
Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Enrollment
574 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT06667154 Phase 2
Recruiting
Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy
Enrollment
33 pts
Location
Brazil
Sponsor
Aline Fusco Fares, MD
NCT07188480
Recruiting
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients
Enrollment
10 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
NCT01720836 Phase 1, Phase 2
Recruiting
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Olivera Finn
NCT06448793
Recruiting
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
Enrollment
55 pts
Location
United Kingdom
Sponsor
Bristol-Myers Squibb
NCT01994057
Recruiting
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
Enrollment
1,000 pts
Location
China
Sponsor
Sun Yat-sen University
NCT05351320 Phase 2
Recruiting
WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC
Enrollment
40 pts
Location
China
Sponsor
Jinming Yu